Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory itp in adults.
about
Current Management of Primary Immune ThrombocytopeniaHelicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of BiogeographyAdult idiopathic thrombocytopenic purpura.Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center.Helicobacter pylori infection and immune thrombocytopenic purpura: an update.Postsplenectomy recurrence of thrombocytopenia with an accessory spleenRituximab is effective for selected patients with chronic steroid-refractory immune thrombocytopenic purpura.Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.Helicobacter pylori-associated immune thrombocytopenia.Management of patients with refractory immune thrombocytopenic purpura.An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura.Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective.A retrospective analysis of therapeutic responses to two distinct corticosteroids in 259 children with acute primary idiopathic thrombocytopenic purpura.Patients' benefit-risk preferences for chronic idiopathic thrombocytopenic purpura therapies.Management of chronic immune thrombocytopenic purpura: targeting insufficient megakaryopoiesis as a novel therapeutic principleLong-term outcomes of a 5-year follow up of patients with immune thrombocytopenic purpura after splenectomyITP: a historical perspective.Severe Thrombocytopenia in an Immune Thrombocytopenic Parturient Non-responder to Medical Line of Treatment: Anaesthetic Management for Splenectomy Combined with Caesarean Section.A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study).Evaluation of 143 cases of immune thrombocytopenic purpura with regards to clinical course and response to treatment.Immune Thrombocytopenic Purpura in Children and Adults: A Comparative Retrospective Study in IRANHow I manage Evans Syndrome and AIHA cases in children.Identifying the characteristics, natural behavioral pattern, and response to therapy in ITP in a multi-center population in Sri Lanka.An evaluation of overall effectiveness and treatment satisfaction with intravenous immunoglobulin among patients with immune thrombocytopenia.Safety and efficacy of a 10% intravenous immunoglobulin preparation in patients with immune thrombocytopenic purpura: results of two international, multicenter studies.Length of stay, hospitalization cost, and in-hospital mortality in US adult inpatients with immune thrombocytopenic purpura, 2006-2012.Immunomodulatory treatments for persistent and chronic immune thrombocytopenic purpura: A PRISMA-compliant systematic review and meta-analysis of 28 studies.Platelet desialylation correlates with efficacy of first-line therapies for immune thrombocytopeniaBorderline thrombocytopenia or mild idiopathic thrombocytopenic purpura?
P2860
Q26779408-308870EE-1037-4052-88D5-E6B43CE307D3Q26865062-8076564B-2557-4BF6-851A-98FC4B5EA1A1Q33358032-FBF00AA3-B028-4A47-B28E-69D09F56FFC1Q33360204-DC1FA978-9D37-4CA7-88F4-DC5FE2F37530Q33361786-E2369761-9A0A-4858-BFD2-C78B6DB0C3C6Q33363217-6FF593CF-52C6-4ACD-ADED-C49E74F6D5C8Q33364313-9D1F2382-591F-4230-9188-FD196049F4CEQ33365619-3766C67E-EC7E-43B4-98EE-5CB5EA28004FQ33369972-0AD2CCB2-B275-46AF-864A-4F84AA56576CQ33372113-4B6390A5-A18D-4B59-AB66-CF32AAC1CFABQ33373074-6767AF30-3133-4679-97C9-B872B40988D7Q33378585-511F5A98-14A1-46D4-8DED-63EF36AE459EQ33386717-5AC611FB-A424-40A6-8D69-7DE5BFE5134DQ33388078-F721B6EA-97FE-4143-8B8A-AB79087E8B34Q33390001-809E0DA0-A169-4DA4-A2ED-6899F148F563Q33393057-15554BBA-EA8B-424C-B624-ADDD25363451Q33394791-3B3E36A0-92B4-4BC1-B234-CFCDD35FB175Q33406162-86E7CFEB-6F01-420A-9ECB-C4932264FA35Q33416569-0D72F6C8-545B-4349-AD82-B07DC7185F32Q33419925-00579BF4-4AAB-422A-9803-F7DA2A16D835Q33420128-F5C84C31-BD65-409E-8F7D-3097BE2C2813Q33428041-01A7E2CA-2EBE-4EDD-923D-F355B9F09658Q33430236-B1D5AC92-0347-462F-AB37-7958E8BA1437Q33431970-342E5F92-2B08-4BAC-8234-41BF5805E9B0Q33436552-76684890-42CC-4E7D-A7A6-28296D675F38Q33439137-F951412B-2169-41CF-98C0-1F613D3605CCQ40046559-7A8642BA-5905-425C-916B-C6F29DB3EC89Q42322058-4A3E3E05-2B5E-4BE3-8F5C-C4DD6C3D807FQ43164587-3B518B6D-C7BC-41CC-8F0A-AF4F2D935452
P2860
Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory itp in adults.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Fifty years of idiopathic thro ...... t of refractory itp in adults.
@ast
Fifty years of idiopathic thro ...... t of refractory itp in adults.
@en
type
label
Fifty years of idiopathic thro ...... t of refractory itp in adults.
@ast
Fifty years of idiopathic thro ...... t of refractory itp in adults.
@en
prefLabel
Fifty years of idiopathic thro ...... t of refractory itp in adults.
@ast
Fifty years of idiopathic thro ...... t of refractory itp in adults.
@en
P2860
P1476
Fifty years of idiopathic thro ...... t of refractory itp in adults.
@en
P2093
Adrian Newland
Drew Provan
P2860
P304
P356
10.1046/J.1365-2141.2002.03669.X
P407
P577
2002-09-01T00:00:00Z